• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » InfraReDx kicks founder Muller upstairs

InfraReDx kicks founder Muller upstairs

February 9, 2011 By MassDevice staff

InfraReDx

Having successfully shepherded the company he founded through clinical trials, raising $100 million and finally winning regulatory clearance, InfraReDx CEO Dr. James Muller is leaving the corner office for a seat as chairman of the board.

Dr. James Muller, who launched InfraReDx in 1999, is stepping aside as CEO for Donald Southard, the former CEO of Zonare Medical Systems. The company is ramping up to introduce its coronary imaging system, LipiScan, which uses intravascular ultrasound to provide images of plaque in blood vessels. Muller will become chairman of the company and will still play a role in day-to-day operations as chief medical officer.

Muller called the succession "a sign of the maturation of InfraReDx as a commercial entity" in prepared remarks. Southard, a 30-year medical device veteran, has stints as president of Datascope Corp., president and CEO of Serviscope Corp., vice president of sales and marketing at Toshiba Medical Systems Inc. and vice president of sales Philips Medical Systems under his belt. He left Mountain View, Calif.-based Zonare (which makes ultrasound devices) last summer.

The LipiScan system won 510(k) clearance from the Food & Drug Administration in September 2010. InfraReDx pulled in $21 million the next month in an equity offering to fund the ensuing commercialization push.

When MassDevice spoke with Muller last summer, he intimated that a succession might be in the cards one day.

“I’ve heard criticisms of physicians not knowing how to run companies. Some have said that the term MD stands for ‘management disaster,’ so I’m aware of that problem," he told us.

"In my defense, when I was in academic medicine I ran a large division and so I had a lot of administrative duties. But the reason that I stay with it is because I want to see heart attacks prevented and I think this is the best way to do it. I did resign my position at Harvard Medical School because I believe in this company."

Filed Under: News Well Tagged With: InfraReDx Inc., Personnel Moves

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy